https://www.selleckchem.com/pr....oducts/rocaglamide.h
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematologic disease characterized by a deregulated complement system, chronic Coombs-negative, intravascular hemolysis, and a variable clinical course with substantial risk to develop thromboembolic events. We analyzed diagnostic and prognostic parameters as well as clinical endpoints in 59 adult patients suffering from PNH in 5 hematology centers in Austria (observation period 1978-2015). Median follow-up time was 5.6 years. The median clone size at diagnosis amounted to 55% and w
Like
Comment
Share
